Navigation Links
Hope for stroke victims
Date:2/8/2011

significantly lessening both cell death and the swelling that can accompany stroke. In the second, a team of neurologists in two different hospitals checked the levels of glutamate and GOT in several hundred stroke victims who were admitted to their hospitals. They found that the most significant predictor of the prognosis how well they would recover at three months and how much brain damage they would suffer was the levels of these two substances. High glutamate levels correlated with a poor outcome, high GOT levels with a better one.

The overall implication of these two papers is that administering GOT might improve a patient's chances of recovering, as well as speeding up the process. In addition to stroke and head trauma, a number of diseases are characterized by an accumulation of glutamate in the brain, including Alzheimer's disease, Parkinson, multiple sclerosis, epilepsy, glaucoma, certain brain tumors and amyotrophic lateral sclerosis, and there is hope that, in the future, treatments to scavenge glutamate could relieve the symptoms and improve the outcomes for a number of neurological problems. Yeda, the technology transfer arm of the Weizmann Institute, holds a patent for this method.


'/>"/>

Contact: Yivsam Azgad
news@weizmann.ac.il
972-893-43856
Weizmann Institute of Science
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Dark Chocolate May Lower Stroke Risk
2. Can Chocolate Lower Your Risk of Stroke?
3. New American Heart Association Survey Finds Heart Disease and Stroke Patients Face Significant Barriers in Obtaining Quality, Affordable Care
4. Low levels of natural antibodies behind stroke
5. Chocolate lovers could be lowering their risk of stroke: Study
6. Connecticut Board Considers Warning About Risk Of Stroke Following Chiropractic Neck Manipulation
7. After a Stroke, High Risk for a Recurrence
8. New edition of landmark stroke textbook
9. Farmers markets offer different strokes for different folks
10. New Successful Treatment Improves Walking Post Stroke
11. Patients Do Better at Hospitals That Follow Stroke Guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... sweetFrog Enterprises, LLC. is pleased ... the 20th sweetFrog store operating in the Lone Star State. The premium frozen yogurt ... in 2014. , The store, located at 2916 US-75, Sherman, TX 38652, will have ...
(Date:8/3/2015)... ... 03, 2015 , ... As reported in a July ... “Atlanta Plastic” is getting attention for moving outside traditional ethnic stereotypes when it ... cast of doctors and patients. Beverly Hills based plastic surgeon Payam Jarrah-Nejad, M.D., ...
(Date:8/3/2015)... NJ (PRWEB) , ... August 03, 2015 , ... ... a finalist in 2015 MarketingProfs Bright Bulb B2B Awards. , The MarketingProfs Bright ... and for B2B brands. BESLER Consulting's campaign for the launch of their Readmissions ...
(Date:8/3/2015)... Somerset, N.J. (PRWEB) , ... August 03, 2015 ... ... advanced delivery technologies and development solutions for drugs, biologics and consumer health products, ... Administration has accepted for review OPKO’s New Drug Application for a new treatment ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... The art ... experience. Learning from her grandmother’s side at a young age, Nasreen Zereshki was extremely ... has decided to share her cookbook Recipes from My Persian Kitchen with the world. ...
Breaking Medicine News(10 mins):Health News:sweetFrog Reopens Texas Store Today 2Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 2Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 3Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Persian Cuisine: Colorful and Extremely Healthy 2
... to extend their reach beyond the youth segments as far as ... For the aging population in Japan has taken to "Brain Train" ... Nintendo has sold 3.3 million of its "Brain Training for Adults" ... out to those who were not interested in video games ... ...
... People plan various phases of their life like education, marriage, ... do not plan for the most important thing - death. ... University of New Mexico's Health Sciences Center wants people to ... ,"We're all going to die. But we do not address ...
... (KSHV) and certain forms of lymphoma has been ... ,Researchers at the National Institute of Allergy ... human cell surface molecule involved in infection by ... Kaposi's sarcoma and certain forms of lymphoma. Kaposi's ...
... sporting sunglasses, don’t be surprised. They don't mean to be ... their looks! //Sunglasses have always afforded creative utility benefits and ... use. There is one more out of the hat use ... who have revealed that sunglasses can help reduce jet lag. ...
... culprit behind childhood obesity is that the amount of junk ... of hours they spend// watching television. Researchers analyzed the dietary ... countries. , It was found that consumption of ... in front of the idiot box. Researchers at the universities ...
... which is a male-dominated Muslim society, five women undergo sex ... are expected to fully cover themselves in public and ban ... relative. ,Hence five Saudi women took a sex ... developed a psychologic complex. ,Al Watan newspaper quoted ...
Cached Medicine News:Health News:Plan for Death, Health Center Advises People 2Health News:Virus Causing Kaposi's Sarcoma Discovered 2Health News:Virus Causing Kaposi's Sarcoma Discovered 3Health News:TV Viewing Increases Intake of Junk Food 2
(Date:8/3/2015)... -- Landauer, Inc. (NYSE: LDR ), a recognized leader ... medical physics services and high quality medical consumable accessories, ... fiscal third quarter 2015 after the market close on ... will also host a conference call for investors on ... (10:00 a.m. Eastern Time). Investors may access the live ...
(Date:8/3/2015)... 3, 2015 AcelRx Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapies for the treatment ... reported financial results for the three and six months ... , On July 23, 2015, the Committee for ... opinion for Zalviso™ for the management of acute moderate-to-severe ...
(Date:8/3/2015)... , Aug. 3, 2015  LEO Pharma supports ... Administration (FDA) to include psoriasis as one of eight ... Development Initiative i .  Psoriasis is an autoimmune disease ... subsequent comorbidities, affecting 7.5 million people in the US ... Pharma,s ongoing commitment to supporting patients living with psoriasis, ...
Breaking Medicine Technology:Landauer, Inc. Announces Date And Time For Announcement Of Fiscal Third Quarter 2015 Results And Conference Call 2AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 2AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 3AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 4AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 5AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 6AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 7AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 8AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 9AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results 10LEO Pharma Supports the FDA's Selection of Psoriasis as a Priority Disease 2LEO Pharma Supports the FDA's Selection of Psoriasis as a Priority Disease 3
... Inc.,(Nasdaq: ITMN ) today announced that it ... pirfenidone in idiopathic pulmonary fibrosis (IPF) prior,to market open ... conference,call and webcast, with accompanying slide presentation, to discuss ... a.m. PST) on Tuesday,February 3. , ...
... led by Laurie Ozelius, Ph.D. at Mount Sinai School ... development of primary torsion dystonia, also known as DYT6 ... Research Foundation (DMRF), Dr. Ozelius and her colleagues have ... dystonia in Amish-Mennonite families, as well as in other ...
Cached Medicine Technology:InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3 2Genetic Research Leads to New Discovery in Understanding Rare Neurological Disorder 2
... low osmolar, nonionic, contrast media agent ... inert when injected intra-arterially. Each milliliter ... ioversol, 3.6 mg of tromethamine as ... edetate calcium disodium as a stabilizer. ...
... OMNIPAQUE is an X-ray ... adults and children for: angiography, ... and computed tomography of the ... Arthrography, endoscopic retrograde cholangio (pancreato) ...
... IMAGOPAQUE is a non-ionic monomeric contrast medium ... adults and children. After a decade of ... million examinations, IMAGOPAQUE has proven to be ... in hundreds of radiology departments.Results from large ...
... The only MR contrast agent FDA-approved for ... a gadolinium based, IV contrast media for ... liver. OptiMARK has convenient packaging options ... packaged for efficient, problem-free delivery. You can ...
Medicine Products: